Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma - Wikidata - awgldk - TriplyDB

Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma

Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma

http://www.wikidata.org/entity/Q27478384

about

Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatoma Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope Status of hepatitis C virus vaccination: Recent update Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virus Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design The hepatitis C virus glycan shield and evasion of the humoral immune response Neutralizing antibody response to hepatitis C virus Microbial Cryptotopes are Prominent Targets of B-cell Immunity Identification of a Broadly Cross-Reacting and Neutralizing Human Monoclonal Antibody Directed against the Hepatitis C Virus E2 Protein Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2 In vitro selection of a neutralization-resistant hepatitis C virus escape mutant Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1 Discrete conformations of epitope II on the hepatitis C virus E2 protein for antibody-mediated neutralization and nonneutralization Persistent growth of a human plasma-derived hepatitis C virus genotype 1b isolate in cell culture Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay.Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation Immune control and failure in HCV infection--tipping the balance.Development of hepatitis C virus vaccines: challenges and progress.Fine mapping of murine antibody responses to immunization with a novel soluble form of hepatitis C virus envelope glycoprotein complex.Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.Characterization of Anti-HCV Antibodies in IL-10-Treated Patients The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c Mice.Temporal variations in the hepatitis C virus intrahost population during chronic infection.Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2 Adaptive immunity to hepatitis C virus.A systematic analysis of a broadly neutralizing antibody AR3C epitopes on Hepatitis C virus E2 envelope glycoprotein and their cross-reactivity A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.Neutralizing antibodies in hepatitis C virus infection.Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activity

P2860

Q21245093-80D9856E-F87A-4B06-85C5-A8AE442D4FDF Q26700120-07CCC6A6-570D-4441-8A36-BC1AE74FA1D4 Q26774612-BD6EC2A3-F591-47E8-8CBB-69F335B18344 Q26783378-25690E33-8B72-412C-8DD5-7198D5746FAD Q26801759-3B2F5A58-97BB-4508-A303-422B8787D430 Q27023390-C8DBCD7C-5071-441D-B987-117FD7992339 Q27027484-093C2403-76B1-49A3-8A2C-329FCD27648E Q27468862-08B398CB-1ED5-418A-B614-D9A77C27011E Q27485318-5B81DF0E-1CF8-4522-9DF6-F9114789B75A Q27485325-7F180C02-D744-4EB4-A6D0-DF13AD2689FA Q27485929-A9BD8CF3-A5B3-4829-8B57-2C5CA1314B08 Q27487549-5FAC7D73-BF46-472C-A3D4-0CF041688FB3 Q27488724-F053FA02-6430-47A9-A701-5E8FA8E41BE8 Q27677400-9B2E234B-2F1B-4BB5-B5AE-220783509385 Q27678252-71633D5A-9EF6-4713-A6B9-3A3CE31FDF9C Q27679280-1266CE6B-BF39-4BB4-8C5E-767EA53C8688 Q27684579-0CC2D1ED-AEBC-41D3-8F24-D4E7BA0CDDEF Q28473992-02C8FFC9-8C06-4875-9893-E87F659F3636 Q28482261-FA2ADEEC-5DDE-4CA0-A1C3-30E7358D85D7 Q28483065-33953FB5-720E-4D7F-A7AF-75F628C88ADB Q28552909-864D7450-F77B-4D6A-A11C-12ED67CF76B8 Q28731355-363B2729-E83F-456E-BCC7-A4D782EF5D4D Q30374314-7A54BE1F-552D-4933-BFCA-E312C4DA61E4 Q33939405-68E081A3-F892-497C-9BBD-B67B932E59F1 Q34096483-7D1484EC-A39C-4435-AFF6-F85EAF942A60 Q34178628-99C4A370-5E3C-4A73-9952-1EC15C46629C Q34254941-70307891-4AE5-4F2A-B5E5-4A66D355DBAC Q34262165-3DD04D0F-23E0-4B0A-B93C-43CE7A345B69 Q34291876-925541BD-504E-47CD-8201-B61819CCD833 Q34296870-36FD8EAB-2661-4CE5-B512-5FDF6F1E3CB7 Q34481429-ED7E735B-85EC-4CFF-B73C-D8B3E83EA9C1 Q34546149-C6974538-C430-4998-8FBF-8262492DDE70 Q35077466-BDBFC7D1-540C-4161-9210-0F3882BC1F17 Q35231331-4BB3B7B4-6D64-45F3-8EB1-5FF683E0B3C6 Q35259748-748959BE-B816-4ACB-ACF6-66AA159D9DFC Q35872590-96AFFE27-9A3B-43ED-A4C3-90F727571D32 Q35885451-118BFDB7-4FF0-4636-89BD-0AA57B8A1D92 Q36179699-0511A1E1-7E3A-4163-B5A5-D8AE476F5645 Q36318779-730A1780-16EB-4D48-8C78-6E4A61A50FD8 Q36378193-21BA8A90-774B-4835-B66B-AF9C62DCA2C2

P2860

Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma

http://www.wikidata.org/entity/Q27478384

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Hepatitis C virus epitope-spec ...... Igs prepared from human plasma

@ast

Hepatitis C virus epitope-spec ...... Igs prepared from human plasma

@en

Hepatitis C virus epitope-spec ...... Igs prepared from human plasma

@nl

type

label

Hepatitis C virus epitope-spec ...... Igs prepared from human plasma

@ast

Hepatitis C virus epitope-spec ...... Igs prepared from human plasma

@en

Hepatitis C virus epitope-spec ...... Igs prepared from human plasma

@nl

prefLabel

Hepatitis C virus epitope-spec ...... Igs prepared from human plasma

@ast

Hepatitis C virus epitope-spec ...... Igs prepared from human plasma

@en

Hepatitis C virus epitope-spec ...... Igs prepared from human plasma

@nl

P1433

Q27478384-57215ED4-8E3C-4563-A144-3E34F14DAE1C

P1476

Q27478384-EA1A3668-A5F6-406B-891D-EB0DF18726B3

P2093

Q27478384-1E2E52AE-56E3-4CA0-B04C-F701A66A20FD

Q27478384-2C50550B-EEEC-45B0-B30A-036769E86B8D

Q27478384-2CEB48EF-6AB8-4F9F-BF2F-6BDD3EE8C46A

Q27478384-3A48EE0A-123A-4DBA-90A2-0F9DE4BCF3B9

Q27478384-6C660912-A70C-4E64-A44F-40ABC320F2D8

Q27478384-96F3844C-7879-4DF3-9E25-F66315AD877A

Q27478384-A2C1FA96-12A4-4D19-9593-8B17E99711D7

P2860

Q27478384-11FBD3B4-6495-4087-9169-61D8CC968CEE

Q27478384-1287B113-4C86-453E-812D-1920BEB369F3

Q27478384-1D981B36-1483-4053-AD65-663443BE34F2

Q27478384-2D0212B4-FBDE-4102-9E80-99962FF811BA

Q27478384-31C572B4-BF8E-47DE-AB22-D1B356DF3D73

Q27478384-339C5E11-5206-410D-A6C2-4FE19D7DC609

Q27478384-3622F47A-7302-4266-9C33-BEAC6BB05392

Q27478384-407FEA54-16DE-4A19-9583-0A561CF59542

Q27478384-41E7D859-5CDB-4110-8CC5-E0776B81B5DB

Q27478384-5A6F5A56-124D-4E5E-BDB1-5148A780EA81

P304

Q27478384-4884B4D4-5BC6-49B3-8E51-0764320F1D1D

P31

Q27478384-8C9D9DC4-3531-45AA-AD13-9DB97CE6E0E2

P3181

Q27478384-0B0E9B4C-EFC8-4B67-B9C3-75FCE7B24619

P356

Q27478384-6CC5B33E-84A9-487A-99B0-7665FFF81F1D

P407

Q27478384-B828F37B-DF8D-4443-A553-0D83B7561B04

P433

Q27478384-F4CDEB50-697D-4C57-AC3D-CFF951E1493E

P478

Q27478384-9BE960D7-D83C-4A5D-84BD-A3E0FDFFF00D

P577

Q27478384-567E453B-158D-46CB-969F-7700F2B62842

P5875

Q27478384-C3A3F275-28D7-4876-8EBF-CED4F75D684E

P698

Q27478384-F36B2292-FCB3-4DAD-B287-4DEDB59E6575

P921

Q27478384-EEB76223-5927-4C1E-B891-C05312982641

Q27478384-FDEEAE2F-C96E-4A65-A469-11E1D9CDA5F3

P932

Q27478384-5EBCF080-A313-4913-B38D-8B2468671486

P3181

P356

PNAS.0703039104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Hepatitis C virus epitope-spec ...... Igs prepared from human plasma

@en

P2093

Charles G Wu

http://www.w3.org/2001/XMLSchema#string

Harvey J Alter

http://www.w3.org/2001/XMLSchema#string

Kathleen Mihalik

http://www.w3.org/2001/XMLSchema#string

Maria Luisa Virata-Theimer

http://www.w3.org/2001/XMLSchema#string

Mei-Ying W Yu

http://www.w3.org/2001/XMLSchema#string

Pei Zhang

http://www.w3.org/2001/XMLSchema#string

Stephen M Feinstone

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes

Complete replication of hepatitis C virus in cell culture

P304

8449-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2833983

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0703039104

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6336708

http://www.w3.org/2001/XMLSchema#string

P698

17494735

http://www.w3.org/2001/XMLSchema#string

P921

P932

1866310

http://www.w3.org/2001/XMLSchema#string